
Monthly Client Webinar
After reviewing your feedback there was a brief macro overview and a look at US equity markets. The current bull trigger in the Help strategy was examined, followed by a discussion on Moderna (MRNA). A trade in Xeris Pharma (XERS) on the FBD strategy closed the session.